Status:
COMPLETED
Evaluation of Eflornithine on Facial and Forearm Skin
Lead Sponsor:
Allergan
Conditions:
Hirsutism
Eligibility:
FEMALE
18-85 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate whether regular use of eflornithine 11.5% cream in treating women with facial hair will induce skin damage (atrophy) on the face and/or forearms
Eligibility Criteria
Inclusion
- Female subjects with clinical diagnosis of facial hirsutism/excessive facial hair
- Women of childbearing potential must agree to use an effective form of birth control for the duration of the study
- Skin type I-IV
- Customary frequency of removal of facial hair two or more times per week
Exclusion
- Pregnant or lactating women
- Severe inflammatory acne or presence of significant scarring on the face
- History of skin malignancy
- Connective tissue disorders
Key Trial Info
Start Date :
November 30 2004
Trial Type :
INTERVENTIONAL
End Date :
October 31 2005
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT00152048
Start Date
November 30 2004
End Date
October 31 2005
Last Update
October 30 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.